FORWARD-LOOKING STATEMENTS

WASHINGTON, Jan. 8, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has received…

WILMINGTON, Del., Dec. 29, 2025 /PRNewswire/ — Brand Engagement Network Inc. (Nasdaq: BNAI) (“BEN” or the “Company”), a…

Vigoride‑7 to launch on SpaceX’s Transporter‑16 delivering several innovative payloads to advance capabilities in space SAN JOSE, Calif.,…

Rocket Lab Corporation LONG BEACH, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket…

FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of…

Singapore, Singapore–(Newsfile Corp. – November 21, 2025) – Mobile-health Network Solutions (NASDAQ: MNDR) (“MNDR” or the “Company”), a…

Rocket Lab Corporation LONG BEACH, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket…

Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE…

Rocket Lab Corporation MAHIA, New Zealand, Oct. 14, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket…

New advancement lays groundwork for quantum-enhanced modeling in carbon capture and molecular dynamics COLLEGE PARK, Md., October 13,…

Rocket Lab Corporation LONG BEACH, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket…

SAN JOSE, Calif., October 09, 2025–(BUSINESS WIRE)–Momentus Inc. (NASDAQ: MNTS), a U.S. commercial space company offering satellites, satellite…

Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder